Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

0.6368 +0.0268 (+4.39%)
Streaming Delayed Price Updated: 11:15 AM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Enveric Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Enveric Biosciences Reports First Quarter 2025 Financial and Corporate Results
From Enveric Biosciences
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024
From Enveric Biosciences
Via Business Wire
Enveric Biosciences Participating in BIO-Europe Spring®
From Enveric Biosciences, Inc.
Via Business Wire
Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark
From Enveric Biosciences
Via Business Wire
Keep an eye on the top gainers and losers in Friday's session.
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements. 
Via Chartmill
These stocks have an unusual volume in today's session
Volume analysis on 2025-02-28: stocks with an unusual volume in today's session. 
Via Chartmill
Enveric Biosciences CEO Issues Letter to Shareholders
From Enveric Biosciences
Via Business Wire
These stocks are moving in today's after hours session
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
What's going on in today's session
Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
Check out the stocks that are attracting the most attention and driving market activity.
Let's dive into the action on the US markets on Wednesday. Here are the most active stocks that are driving the market today. 
Via Chartmill
Dow Dips Over 100 Points; TJX Earnings Top Views
 
Via Benzinga
Topics Stocks
Here are the top movers in Wednesday's session.
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
Nasdaq Surges 150 Points; Lowe's Posts Upbeat Earnings
 
Via Benzinga
Small-Caps Under $2 on the Move: ENVB, ONVO, TRNR, PRSO, PNPN.V Gaining Momentum
Via AB Newswire
Topics Artificial Intelligence Derivatives Intellectual Property
Traders are paying attention to the gapping stocks in Wednesday's session.
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday. 
Via Chartmill
These stocks are moving in today's pre-market session
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
US Stocks Likely To Open Higher Ahead Of Nvidia Earnings: S&P 500's Four-Day Fall Was A 'Non-Event,' Says Expert
U.S. stock futures rose on Wednesday following two consecutive days of mixed close this week. All futures advanced in premarket trading. 
Via Benzinga
Topics Stocks
Why ZoomInfo Technologies Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Which stocks are moving after the closing bell on Tuesday?
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
EXCLUSIVE: Non-Hallucinogenic Psychedelic Compounds Show Promise For Treating Addiction And ADHD
Enveric Biosciences secures a U.S. patent for non-hallucinogenic mescaline derivatives targeting addiction, ADHD and anxiety. 
Via Benzinga
Topics Derivatives Intellectual Property
Enveric Biosciences Unveils EVM401 Series of Compounds with New U.S. Patent
From Enveric Biosciences
Via Business Wire
Enveric Biosciences Inks Two Licensing Agreements With Restoration Biologics To Treat Joint Disease
Enveric's Akos Biosciences licensed its cannabinoid-COX-2 conjugate technology to Restoration Biologics for joint disease treatments, including osteoarthritis. 
Via Benzinga
Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease
From Enveric Biosciences
Via Business Wire
Enveric Biosciences Announces Closing of $5 Million Public Offering
From Enveric Biosciences, Inc.
Via Business Wire
What's going on in today's session
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
Dow Edges Lower; Exxon Mobil Earnings Top Views
 
Via Benzinga
Topics Stocks
Which stocks are gapping on Friday?
The market is buzzing with gapping stocks on Friday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
Nasdaq Jumps Over 150 Points; Apple Posts Upbeat Earnings
 
Via Benzinga
These stocks are moving in today's pre-market session
Before the opening bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.